Yes, Continue Cephalexin (Keflex) Based on Susceptibility Results
Since your urine culture demonstrates susceptibility to all cephalosporins including cephalexin, it is appropriate and safe to continue the patient on Keflex. The culture results have confirmed that the organism is susceptible to the antibiotic she is already taking, which is the ideal scenario for antimicrobial stewardship.
Key Reasoning
Susceptibility Testing Trumps Empiric Concerns
The resistance to ampicillin is irrelevant here because:
- Ampicillin resistance does not predict cephalosporin resistance - these are different β-lactam classes with distinct resistance mechanisms
- Your culture explicitly shows susceptibility to cephalosporins, which directly answers whether Keflex will work
- Guidelines emphasize tailoring therapy based on susceptibility results once available 1
Guideline Support for Cephalexin in UTI
While cephalexin is considered a second-line agent for empiric treatment of uncomplicated cystitis due to inferior efficacy compared to nitrofurantoin or TMP-SMX 1, this limitation applies only to empiric therapy. The 2011 IDSA guidelines state that β-lactams including cephalexin "may also be appropriate in certain settings" 1, and when susceptibility is confirmed, this becomes one of those appropriate settings.
The 2024 guidelines recommend first-generation cephalosporins as reasonable first-line agents for pyelonephritis when local resistance rates support their use 2. Your susceptibility data provides exactly that confirmation.
Duration of Therapy
- For uncomplicated cystitis: Continue for 3-7 days total 1
- For pyelonephritis: Complete 7 days of β-lactam therapy 2
The specific duration depends on whether this is cystitis versus pyelonephritis based on clinical presentation (fever, flank pain, systemic symptoms).
Important Caveats
Monitor clinical response: Even with susceptibility, β-lactams have somewhat lower cure rates than other agents 1. If symptoms persist or worsen after 48-72 hours despite documented susceptibility, consider:
- Inadequate source control (obstruction, abscess)
- Incorrect diagnosis
- Poor drug absorption or compliance
Ampicillin resistance pattern: The fact that the organism is ampicillin-resistant but cephalosporin-susceptible suggests this is likely E. coli with plasmid-mediated ampicillin resistance, which does not affect cephalosporin activity. This is a common and expected pattern 1.
Do not use ampicillin empirically: Guidelines explicitly state ampicillin should not be used for empiric UTI treatment due to high resistance rates worldwide 1, but this doesn't impact your cephalexin decision.